Reports of echinocandin-resistant Candida auris in healthcare settings

The Centers for Disease Control is calling Candida auris a ‘global emerging threat’.  Pan-resistant C. auris isolates have been reported previously, although rarely, from the United States. Echinocandins are critical for treatment of C. auris infections and are recommended as first-line therapy for most invasive Candida infections, but the Antibiotic Resistance Laboratory Network has detected independent clusters of pan-resistant or echinocandin-resistant […]

Antifungal agents in biopolymer hydrogel wound dressing

A team from Wolverhampton, UK and Zabrze, Poland have made some interesting discoveries when using hydrogel as a method to administer antifungals within wound dressings. Wounds from various sources that have been in a prolonged state of irritation and rubor, with a high degree of exudate, are decidedly prone to becoming infected by various opportunistic […]

COVID-19 reverses gains in survival rates of HIV patients

Guatemala’s leading HIV centre reported that deaths from HIV rose from 16.6% to 27.3% during COVID-19. Just published in the International Journal of Infectious Diseases – Narda Medina and colleagues charted the provision of HIV care in Guatemala and how the global pandemic has affected diagnosis and treatment. Patient attendances and rapid services were also […]

Turkish review of mucormycosis in children shows high mortality rate and importance of urgent evaluation when infection is suspected

A new paper published by the Çukurova University Faculty of Medicine in Adana, Turkey, re-examines historical cases of mucormycosis in children. Mucormycosis is an emerging fungal infection with poor health outcomes. This infection is of particular interest due to its links to increased fatalities in the COVID-19 outbreak in India. This retrospective review focuses on […]

Scroll to top